Oradexon (Dexamethasone Sodium Phosphate)

Dexamethasone sodium phosphate, the active ingredient in Oradexon, is a corticosteroid presented as a sterile injectable solution for intravenous or intramuscular use. It reduces inflammation and modulates immune responses in a range of acute and chronic conditions.\n\nGNH India supplies Oradexon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Dexamethasone sodium phosphate is a systemic corticosteroid that suppresses inflammation and immune activity.\n\nAllergic reactions: rapidly alleviates severe hypersensitivity symptoms.\nAsthma exacerbations: improves airway inflammation and breathing function.\nCerebral edema: decreases intracranial pressure associated with tumors or trauma.\nRheumatic disorders: mitigates joint swelling and pain in conditions such as rheumatoid arthritis.\nOncologic therapy support: reduces chemotherapy‑induced nausea and inflammatory complications.

Adverse reactions may vary with dose, duration, and patient factors.\n\nCommon Side Effects:\n- Elevated blood glucose levels.\n- Mood changes such as irritability or euphoria.\n- Gastro‑intestinal discomfort or ulceration.\n- Fluid retention causing mild edema.\n- Increased susceptibility to minor infections.\n\nSerious or Rare Side Effects:\n- Severe hyperglycemia or diabetic ketoacidosis.\n- Opportunistic infections including fungal or viral.\n- Osteonecrosis of the jaw or avascular necrosis.\n- Adrenal insufficiency on abrupt discontinuation.\n- Severe psychiatric disturbances such as psychosis.

Careful assessment and monitoring are required before and during therapy.\n\nAssess infection risk: evaluate for active bacterial, viral, or fungal infections before initiating.\nMonitor glucose: check blood sugar regularly in diabetic or pre‑diabetic patients.\nScreen for osteoporosis: consider bone density testing for long‑term users.\nAvoid abrupt cessation: taper the dose gradually to prevent adrenal crisis.\nStore at 2-8°C: keep refrigerated, protect from light, do not freeze.

Dexamethasone sodium phosphate can alter the pharmacokinetics or effects of several medicines.\n\nMajor Interactions (Avoid):\n- CYP3A4 inhibitors (e.g., ketoconazole): may increase systemic exposure and toxicity.\n- Live vaccines: risk of uncontrolled infection due to immunosuppression.\n\nModerate Interactions (Monitor Closely):\n- Anticoagulants (warfarin): may enhance anticoagulant effect, requiring INR monitoring.\n- Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase risk of gastrointestinal ulceration.\n- Diuretics: may exacerbate electrolyte imbalances, especially potassium loss.